PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections

Landa, Guillermo ; Aguerri, Laura (Universidad de Zaragoza) ; Irusta, Silvia ; Mendoza, Gracia ; Arruebo, Manuel (Universidad de Zaragoza)

Resumen: Staphylococcus aureus possesses the ability to become pathogenic, leading to severe and life-threatening infections. Its methicillin-resistant variant MRSA has garnered high-priority status due to its increased morbidity and associated mortality. This emphasizes the urgency for novel anti-staphylococcal agents. The bacteriocin lysostaphin stands out for its remarkable bactericidal activity against S. aureus, including MRSA, outperforming conventional antibiotics. However, the clinical application of lysostaphin faces challenges, including enzymatic activity loss under physiological conditions and potential immunogenicity. This study introduces a novel approach by encapsulating lysostaphin within polylactic-co-glycolic acid (PLGA) nanoparticles, a biodegradable copolymer known for its biocompatibility and sustained drug release ability. The study assesses the antimicrobial activity of lysostaphin-loaded PLGA nanoparticles against different S. aureus strains, and we also used GFP-expressing S. aureus for facilitating its traceability in planktonic, biofilm, and intracellular infection models. The results showed the significant reduction in bacteria viability both in planktonic and biofilm states. The in vitro intracellular infection model demonstrated the significantly enhanced efficiency of the developed nanoparticles compared to the treatment with the free bacteriocin. This research presents lysostaphin encapsulation within PLGA nanoparticles and offers promising avenues for enhancing lysostaphin's therapeutic efficacy against S. aureus infections.

Idioma: Inglés

DOI: 10.1016/j.ijbiomac.2024.132563

Año: 2024

Publicado en: International journal of biological macromolecules 271, Part 1 (2024), 132563 [11 pp.]
ISSN: 0141-8130

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/MS19-00092
Financiación: info:eu-repo/grantAgreement/ES/MCINN/PRE2018-085769
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PDC2021-121405-I00
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PID2020-113987RB-I00

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Química Analítica (Dpto. Química Analítica)
Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)